Jim Cramer Says Medline IPO “Went so Well” That it Looks “A Little Too Expensive”

“So is Medline worth buying after today’s IPO and the stock’s subsequent rally? This was a very successful deal with the stock up more than 41% today. Initially, Medline was only looking to sell 179 million shares for $26 to $30, but the demand was so high that they sold over 216 million shares at $29. Today, Medline opened for trading at $35, up over 20% from the offer price, and then it added a few more bucks after that. At the current price, Medline has a market capitalization of roughly $54 billion, mak ...